Effects of gelatine and medium molecular weight starch as priming fluid in cardiopulmonary bypass - A randomised controlled trial

Perfusion

Volumn 22, Issue 1, 2007, Pages 57-62

  Yap, Wan Wan ^a,c   Young, D ^b   Pathi, V ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GELATIN SUCCINATE; HETASTARCH;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FLUID THERAPY; HEMATOLOGICAL PARAMETERS; HUMAN; INTRAOCULAR PRESSURE; INTRAOPERATIVE PERIOD; MALE; ONCOTIC PRESSURE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

AGED; BLOOD LOSS, SURGICAL; CARDIOPULMONARY BYPASS; COLLOIDS; DOUBLE-BLIND METHOD; FEMALE; GELATIN; HETASTARCH; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PLASMA SUBSTITUTES; POLYGELINE; STARCH;

EID: 34347388218     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/0267659107077903     Document Type: Article

References (16)

1. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993 Feb. 55 (2): 552-59.
2. Khabar KS, elBarbary MA, Khouqeer F. Devol E, al-Gain S, al-Halees Z. Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlation with duration of bypass and systemic inflammatory response/multiple organ dysfunction syndromes. Clin Immunol Immunopathol 1997 Oct. 85 (1): 97-103.
3. Sade RM, Stroud MR, Crawford FA Jr., Kratz JM, Dearing JP, Bartles DM. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass. J Thoracic Cardiovasc Surg 1985 May. 89 (5): 713-22.
4. Boldt J, Zickmann B, Ballesteros M, Stertmann F, Hempelmann G. Influence of five different priming solutions on platelet function in patients undergoing cardiac surgery. Anaesth Analg 1992; 74: 219-25.
5. Shore-Lesserson L, Manspeizer HE, Deperio M, et al. Thrombo elastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anaesth Analg. 1999; 88: 312-19.
6. Larkin DFP, Murphy R, Magne JB, Eustace P. Management of intra-ocular pressure during cardiopulmonary bypass. Acta Ophthalmol 1987; 65: 591-93.
7. Larkin DFP, Connolly P, Magner JB, Wood AE, Eustace P. Intra-ocular pressure during cardiopulmonary bypass. Br J Ophthalmol 1987; 71: 177-80.
8. Abbott MA, McLaren AD, Algie T. Intra-ocular pressure during cardiopulmonary bypass - a comparison of crystalloid and colloid priming solutions. Anaesthesia 1994; 49: 343-46.
9. Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med 1999; 25: 258-68.
10. Strauss RG, Stansfield C, Henriksen RA, Villhauer PJ. Pentastarch may cause fewer effects on coagulation than hetastarch. Transfusion 1988; 28: 257-60.
11. Treib J, Haass A, Pindur G. Coagulation disorders caused by hydroxyethyl starch. Thromb Hemost 1997; 78: 974-83.
12. Gallandat Huet RC, Siemons AW, Baus D. A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anesth 2000; 47: 1207-15.
13. Allison KP, Gosling P, Jones S, Pallister I, Porter KM. Randomized trial of hydroxyethyl starch versus gelatine for trauma resuscitation. J Trauma 1999 Dec.47 (6): 1114-21.
14. Sade RM, Crawford FA Jr., Dearing JP, Stroud M. Hydroxyethyl starch in priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1982 Jul. 84 (1): 35-38.
15. Tokuyama T, Ikeda T, Sato K. Effect of plasma colloid osmotic pressure on intraocular pressure during haemodialysis. Br J Ophthalmol 1998 Jul. 82 (7): 751-53.
16. Murphy M, Carmichael AJ, Lawler PG, White M, Cox NH. The incidence of hydroxyethyl starch-associated pruritus. Br J Dermatol 2001 May. 144 (5): 973-6.